FDA Adverse Event Injury Summary report: N

LENSX LASER SYSTEM

MDR report key: 6060704 · Received October 27, 2016

Report

Report Number
3008772169-2016-00709
Event Type
Injury
Date Received
October 27, 2016
Report Date
December 13, 2016
Manufacturer
ALCON LENSX, INC.
Product Code
OOE
PMA / PMN Number
K101626
Removal / Correction Number
NA
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

INVESTIGATION, INCLUDING ROOT CAUSE ANALYSIS, IS IN PROGRESS. A SUPPLEMENTAL MDR WILL BE FILED AS NECESSARY IN ACCORDANCE WITH 21 CFR 803.56 WHEN ADDITIONAL REPORTABLE INFORMATION BECOMES AVAILABLE. THE DEVICE HISTORY RECORDS (DHR) FOR THE DEVICE WAS REVIEWED. THE ASSOCIATED DEVICE WAS RELEASED BASED ON COMPANY ACCEPTANCE CRITERIA. ADDITIONAL INFORMATION HAS BEEN REQUESTED. (B)(4).

Additional Manufacturer Narrative · 1

ATTEMPTS HAVE BEEN MADE TO OBTAIN ADDITIONAL INFORMATION; HOWEVER, NO INFORMATION HAS BEEN PROVIDED TO DATE. SULCUS IMPLANT COMPLICATIONS AND VITRECTOMY OCCURRENCES ARE RELATED TO THE OCCURRENCE OF TEARS IN THE POSTERIOR CHAMBER. OTHER CONTRIBUTING FACTORS SUCH AS SURGICAL TECHNIQUE, PATIENT ANATOMY, AND MOVEMENT ALSO CONTRIBUTE TO A POSTERIOR CAPSULE TEAR. BASED ON THE INFORMATION OBTAINED, THE ROOT CAUSE OF THE REPORTED EVENT CANNOT BE DETERMINED CONCLUSIVELY. (B)(4).

Description of Event or Problem · 1

A SURGEON REPORTED HE FEELS HE HAS HAD AN INCREASED NUMBER OF POSTERIOR CAPSULE TEARS WITH ANTERIOR VITRECTOMY AND INTRAOCULAR LENS (IOL) IMPLANTS IN THE SULCUS WITH LASER ASSISTED CATARACT PROCEDURES. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

Description of Event or Problem · 1

ATTEMPTS HAVE BEEN MADE TO OBTAIN ADDITIONAL INFORMATION; HOWEVER, NO INFORMATION HAS BEEN PROVIDED TO DATE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
712795 LENSX LASER SYSTEM OPHTHALMIC FEMTOSECOND LASER OOE ALCON LENSX, INC. 550 NA

Patients

Seq Age Sex Outcome Treatment
1 Other| R